Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
6
×
biotech
6
×
clinical trials
life sciences
national blog main
boston blog main
fda
national top stories
new york blog main
boston top stories
eli lilly
new york top stories
alirocumab
alnylam pharmaceuticals
calcitonin gene-related peptide
chronic migraine
deals
drugs
episodic migraine
evolocumab
inclisiran
indiana blog main
indiana top stories
migraine
national
new york
novartis
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
san francisco blog main
san francisco top stories
sanofi
teva pharmaceutical
abbvie
alder biopharmaceuticals
allergan
biohaven
boulder/denver blog main
boulder/denver top stories
What
medicines
6
×
drug
new
fda
class
migraine
approval
approved
cholesterol
developed
medco
nod
pain
starts
won
acquire
adults
agreed
allergan
alnylam
amgen
announced
based
billion
brings
cancer
candidates
cash
company
compound
data
deal
decision
despite
eli
evidence
family
gets
hardest
head
Language
unset
Current search:
biotech
×
medicines
×
amgen
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines